Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study

被引：0
|
作者：
Ortega, Hector
Liu, Mark
Pavord, Ian
Brusselle, Guy
FitzGerald, J. Mark
Chetta, Alfredo
Katz, Lynn
Keene, Oliver
Yancey, Steven
Chanez, Pascal
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Exacerbation; Asthma; -; management; Inflammation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2906
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Exacerbations of severe asthma in patients treated with mepolizumab
    Shrimanker, Rahul
    Pavord, Ian D.
    Yancey, Steve
    Heaney, Liam G.
    Green, Ruth H.
    Bradding, Peter
    Hargadon, Beverley
    Brightling, Chris E.
    Wardlaw, Andrew J.
    Haldar, Pranabashis
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (06)
  • [22] The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
    McDowell, P. Jane
    Diver, Sarah
    Yang, Freda
    Borg, Catherine
    Busby, John
    Brown, Vanessa
    Shrimanker, Rahul
    Cox, Ciara
    Brightling, Christopher E.
    Chaudhuri, Rekha
    Pavord, Ian D.
    Heaney, Liam G.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1174 - 1184
  • [23] A Meta-Analysis Of Exacerbations Requiring Hospitalization From Studies Of Mepolizumab In Severe Eosinophilic Asthma
    Pavord, I.
    Ortega, H.
    Keene, O.
    Mayer, B.
    Yancey, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [24] Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Nazik Bahcecioglu, Sakine
    Turk, Murat
    Tutar, Nuri
    Pacaci Cetin, Gulden
    Arslan, Bahar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1953 - 1959
  • [25] Clinical usefulness of mepolizumab in severe eosinophilic asthma
    Menzella, Francesco
    Lusuardi, Mirco
    Montanari, Gloria
    Galeone, Carla
    Facciolongo, Nicola
    Zucchi, Luigi
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 907 - 916
  • [26] Use of Mepolizumab in the Treatment of Severe Eosinophilic Asthma
    Strauss, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Mepolizumab, quality of life, and severe eosinophilic asthma
    Pavord, Ian D.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (05): : 362 - 363
  • [28] Mepolizumab for eosinophilic severe asthma: recent studies
    Robinson, Douglas S.
    Kariyawasam, Harsha H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 909 - 914
  • [29] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [30] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
12345